Author Archives: Magdalena Kegel

Mitochondrial Peptides Found in a Preclinical Study Seen to Control Cell Metabolism

CohBar, a developer of mitochondria-based therapeutics, announced that preclinical research by its academic collaborators has found small humanin-like peptides (SHLPs) that can control metabolism and cell survival. The findings have implications for age-related diseases such as Alzheimer’s and cancer. The study, “Naturally Occurring Mitochondrial-derived Peptides are Age-dependent…

Drug to Treat Mitochondrial-related Heart Failure Shows Promise in Clinical Trial, Company Reports

Stealth BioTherapeutics presented new clinical trial data during the recent American College of Cardiology’s 65th Annual Scientific Session in Chicago, showing that its lead candidate elamipretide is both safe and well-tolerated in patients with heart failure. At the April 2–4 meeting, the company also reported demonstrated improvements in major secondary efficacy study measures, and that future…

Severe Mitochondrial Disease Traced to Rare Mutation in OPA1 Gene

A newly found mutation in the OPA1 gene has been linked to a mitochondrial condition involving general brain dysfunction, thickening of the heart muscle, and degeneration of the optic nerve. The report, published in the Journal of Medical Genetics, is the first to describe the severe disease consequences of…

Mitochondrial Teamwork Within Cells Found to Regulate Calcium Flux

Penn State researchers were the first to find the mitochondrial mechanism controlling the levels of calcium inside cells. Disruption of mitochondrial calcium regulation can result in an uncontrollable rise of the molecule inside cells, contributing to a host of neurodegenerative, metabolic, and cardiovascular diseases. The study was performed in the lab of…